Canada markets closed

vTv Therapeutics Inc. (VTVT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
27.90+0.02 (+0.07%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 67.88M
Enterprise Value 15.92M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)72.51
Price/Book (mrq)3.26
Enterprise Value/Revenue 15.92
Enterprise Value/EBITDA -2.11

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-20.56%
S&P500 52-Week Change 326.49%
52 Week High 339.60
52 Week Low 37.38
50-Day Moving Average 324.02
200-Day Moving Average 317.35

Share Statistics

Avg Vol (3 month) 366.23k
Avg Vol (10 day) 33.39k
Shares Outstanding 52.43M
Implied Shares Outstanding 62.44M
Float 8835.88k
% Held by Insiders 138.82%
% Held by Institutions 116.11%
Shares Short (Apr 30, 2024) 426.6k
Short Ratio (Apr 30, 2024) 44.5
Short % of Float (Apr 30, 2024) 43.07%
Short % of Shares Outstanding (Apr 30, 2024) 41.09%
Shares Short (prior month Mar 28, 2024) 432.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Nov 21, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-72.03%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.41M
Net Income Avi to Common (ttm)-20.25M
Diluted EPS (ttm)-9.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.51M
Total Cash Per Share (mrq)3.91
Total Debt (mrq)529k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.00
Book Value Per Share (mrq)-11.84

Cash Flow Statement

Operating Cash Flow (ttm)-19.08M
Levered Free Cash Flow (ttm)2.46M